References
Petrella T, Bagot M, Willemze R et al (2005) Blastic NK-cell lymphomas (agranular CD4+CD56+hematodermic neoplasms): a review. Am J Clin Pathol 123:662
Chaperot L, Bendriss N, Manches O et al (2001) Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 97:3210
Reizis B, Bunin A, Ghosh HS et al (2011) Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 29:163
Julia F, Petrella T, Beylot-Barry M et al (2013) Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol 169:579
Falcone U, Sibai H, Deotare U (2016) A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm. Crit Rev Oncol Hematol 107:156–162
Lucioni M, Novara F, Fiandrino G et al (2011) Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood 118:4591
Rauh MJ, Rahman F, Good D et al (2012) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review. Leuk Res 36:81
Shapiro R, Sangle N, Keeney M, Chin-Yee IH, Hsia CC et al (2015) Blastic plasmacytoid dendritic cell neoplasm: a review of diagnosis, pathology, and therapy. J Cell Sci Ther S8:008. https://doi.org/10.4172/2157-7013.S8-008
Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M et al (2004) TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NKcell lymphomas) and leukemia cutis. Am J Clin Pathol 122:307–313
Sangle NA, Schmidt RL, Patel JL, Medeiros LJ, Agarwal AM et al (2014) Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm. Mod Pathol 27:1137–1143
Julia F, Dalle S, Duru G, Balme B, Vergier B et al (2014) Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol 38:673–680
Facchetti F, Jones DM, Petrella T (2008) Blastic plasmacytoid dendritic cells neoplasm, WHO classification of tumours of hematopoietic and lymphoid tissues. IARC Press, Lyon, pp 145–147
Martin-Martin L, Lopez A, Vidriales B, Caballero MD, Rodrigues AS et al (2015) Classification and clinical behaviour of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile. Oncotarget 6:19204–19216
Angelot-Delettre F, Garnache-Ottou F (2012) Blastic plasmacytoid dendritic cell neoplasm. Blood 120:2784
Taylor J, Kim SS, Stevenson KE et al (2013) Loss-of-function mutations in the splicing factor ZRSR2 are common in blastic plasmacytoid dendritic cell neoplasm and have male predominance [ASH abstract 741]. Blood 122(21):741
Pagano L, Valentini CG, Pulsoni A, Fisogni S, Carluccio P et al (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98:239–246
Tsagarakis NJ, Kentrou NA, Papadimitrou KA, Pagoni M, Kokkini G, for the Hellenic Dendritic Cell Leukemia Study Group et al (2010) Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res 34:438–446
Poret E, Vidal C, Desbrosses Y et al (2015) How to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) patients: results on 86 patients of the French BPDCN network. Blood 126:456
Pagano L, Valentini CG, Pulsoni A et al (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98:239
Julia F, Petrella T, Beylot-Barry M (2013) Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol 169(3):579–586
Frankel AE, Woo JH, Ahn C (2014) Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood 124(3):385–392
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors state that there is no conflict of interest present.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Singh, N., Agrawal, N., Agarwal, P. et al. Blastic Plasmacytoid Dendritic Cell Neoplasm: Still an Enigma. Indian J Hematol Blood Transfus 34, 568–572 (2018). https://doi.org/10.1007/s12288-018-0930-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-018-0930-4